Literature DB >> 18063319

Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism.

Xiao-Qing Peng1, Xia Li, Jeremy G Gilbert, Arlene C Pak, Charles R Ashby, Jonathan D Brodie, Stephen L Dewey, Eliot L Gardner, Zheng-Xiong Xi.   

Abstract

Relapse to drug use is a core feature of addiction. Previous studies demonstrate that gamma-vinyl GABA (GVG), an irreversible GABA transaminase inhibitor, attenuates the acute rewarding effects of cocaine and other addictive drugs. We here report that systemic administration of GVG (25-300 mg/kg) dose-dependently inhibits cocaine- or sucrose-induced reinstatement of reward-seeking behavior in rats. In vivo microdialysis data indicated that the same doses of GVG dose-dependently elevate extracellular GABA levels in the nucleus accumbens (NAc). However, GVG, when administered systemically or locally into the NAc, failed to inhibit either basal or cocaine-priming enhanced NAc dopamine in either naïve rats or cocaine extinction rats. These data suggest that: (1) GVG significantly inhibits cocaine- or sucrose-triggered reinstatement of reward-seeking behavior; and (2) a GABAergic-, but not dopaminergic-, dependent mechanism may underlie the antagonism by GVG of cocaine-triggered reinstatement of drug-seeking behavior, at least with respect to GVG's action on the NAc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063319      PMCID: PMC2574671          DOI: 10.1016/j.drugalcdep.2007.10.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  45 in total

Review 1.  GABA modulation of cocaine self-administration.

Authors:  D C Roberts; K Brebner
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Neurobiology of relapse to heroin and cocaine seeking: a review.

Authors:  Uri Shalev; Jeffrey W Grimm; Yavin Shaham
Journal:  Pharmacol Rev       Date:  2002-03       Impact factor: 25.468

3.  Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization.

Authors:  Taco J De Vries; Anton N M Schoffelmeer; Rob Binnekade; Halfdan Raasø; Louk J M J Vanderschuren
Journal:  Neuropsychopharmacology       Date:  2002-01       Impact factor: 7.853

Review 4.  Critical assessment of how to study addiction and its treatment: human and non-human animal models.

Authors:  Charles P O'Brien; Eliot L Gardner
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

5.  Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study.

Authors:  W K Schiffer; M R Gerasimov; R A Bermel; J D Brodie; S L Dewey
Journal:  Life Sci       Date:  2000-02-18       Impact factor: 5.037

6.  Increased mesolimbic GABA concentration blocks heroin self-administration in the rat.

Authors:  Z X Xi; E A Stein
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

7.  Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors.

Authors:  Diego Centonze; Barbara Picconi; Christelle Baunez; Emiliana Borrelli; Antonio Pisani; Giorgio Bernardi; Paolo Calabresi
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

8.  Comparative studies on the GABA-transaminase immunoreactivity in rat and gerbil brains.

Authors:  T C Kang; S K Park; J H Bahn; J S Chang; S W Cho; S Y Choi; M H Won
Journal:  Mol Cells       Date:  2001-06-30       Impact factor: 5.034

9.  Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats.

Authors:  Andrew C Barrett; S Stevens Negus; Nancy K Mello; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2005-07-20       Impact factor: 4.030

Review 10.  GABAergic mechanisms of opiate reinforcement .

Authors:  Zheng-Xiong Xi; Elliot A Stein
Journal:  Alcohol Alcohol       Date:  2002 Sep-Oct       Impact factor: 2.826

View more
  17 in total

1.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

2.  (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.

Authors:  Yue Pan; Madina R Gerasimov; Trine Kvist; Petrine Wellendorph; Karsten K Madsen; Elena Pera; Hyunbeom Lee; Arne Schousboe; Mary Chebib; Hans Bräuner-Osborne; Cheryl M Craft; Jonathan D Brodie; Wynne K Schiffer; Stephen L Dewey; Steven R Miller; Richard B Silverman
Journal:  J Med Chem       Date:  2011-12-30       Impact factor: 7.446

3.  Evaluating risks for vigabatrin treatment.

Authors:  Gregory L Krauss
Journal:  Epilepsy Curr       Date:  2009 Sep-Oct       Impact factor: 7.500

4.  Use of animal models to develop antiaddiction medications.

Authors:  Eliot L Gardner
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

Review 5.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

Review 6.  The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research.

Authors:  Justin J Anker; Marilyn E Carroll
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

7.  High sensitivity HPLC method for analysis of in vivo extracellular GABA using optimized fluorescence parameters for o-phthalaldehyde (OPA)/sulfite derivatives.

Authors:  Shannon L Zandy; James M Doherty; Nathan D Wibisono; Rueben A Gonzales
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-04-03       Impact factor: 3.205

Review 8.  Plasticity of addiction: a mesolimbic dopamine short-circuit?

Authors:  Jason L Niehaus; Nelson D Cruz-Bermudez; Julie A Kauer
Journal:  Am J Addict       Date:  2009 Jul-Aug

9.  The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats.

Authors:  Xia Li; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2007-11-19       Impact factor: 5.250

Review 10.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.